Informational Funding Webinar: Dissemination and Implementation Research in Health

Event Type:
June 2022

PAR-22-105 (R01)PAR-22-106 (R03)PAR-22-109 (R21)

This webinar provided an opportunity for investigators to learn about NCI’s participation in the set of NIH announcements, “Dissemination and Implementation Research in Health (R01/R21 - Clinical Trial Optional, R03 – Clinical Trial Not Allowed).” These announcements focus on a broad range of topics across multiple NIH Institutes and Centers to build the knowledge base on the dissemination of evidence and the implementation of a range of evidence-based interventions (including practices, programs, tools, treatments, guidelines, and policies). 

As part of this large research agenda, NCI is particularly interested in studies across the cancer control continuum, including in cancer diagnosis, treatment, and survivorship. Examples include (but are not limited to) studies that seek to understand and evaluate sustainable approaches to coordinate cancer treatment across fragmented systems; optimize survivorship care among oncology and non-oncology providers; and improve survivorship care delivery in diverse settings (e.g., community practices, rural settings). NCI is also interested in supporting applications that focus on understanding strategies to promote sustainability and scale-up of effective cancer control interventions; studies that seek to understand de-implementation; studies that seek to advance measures and methods; and studies of the adoption, implementation, and sustainment of cancer control policies.

Last Updated
November 10, 2022